Obstructive Lung Disease

Cystic Fibrosis Updates in Care: Part II — The “Sweat Sticker” and Clinician Q&A

By

Tori Rodriguez, MA, LPC, AHC

Publish Date May 21, 2021

In honor of Cystic Fibrosis Awareness Month, we present a 2-part series on treatment updates in the field, including the “sweat sticker.”

Primary Ciliary Dyskinesia: Practical Pearls for Diagnosis

By

Suzanne Bujara

Publish Date January 28, 2019

Recent guidelines set forth by an interdisciplinary panel assembled by the American Thoracic Society sought to demystify primary ciliary dyskinesia and address 4 main diagnostic questions.

Is There an “Ideal” Cystic Fibrosis Candidate for Lung Transplantation?

By

Suzanne Bujara

Publish Date August 23, 2018

Lung transplantation can extend survival in patients with cystic fibrosis who have compromised lung function and increasing exacerbations.

Using Electronic Health Records to Predict Mortality Post COPD Hospitalization

By

Sheila Jacobs

Publish Date May 9, 2022

For COPD, can electronic health record data predict 90-day post hospitalization mortality — and thereby serve as a risk stratification tool?

Dyspnea in Obesity Linked to Reduction in Lung Volumes, Higher BMIs

By

Sheila Jacobs

Publish Date April 29, 2022

In patients with obesity, what relationships exist between dyspnea in daily living, lung function, and body composition?

Modified Lung Ultrasound for Evaluating Bronchopulmonary Dysplasia Severity

By

Virginia A. Schad, PharmD, RPh

Publish Date April 18, 2022

Researchers adapted the lung ultrasound score to evaluate bronchopulmonary dysplasia severity and short-term clinical outcomes in preterm infants.

ATS Guideline: Outpatient Management of Pediatric Post-Prematurity Respiratory Disease

By

Brandon May

Publish Date April 15, 2022

How should clinicians handle the outpatient management of infants, children, and adolescents with post-prematurity respiratory disease? A summary of updated recommendations from the American Thoracic Society offers guidance.

DCR for Measuring Improved Symptoms, Lung Function After CFTR Triple Therapy

By

Sheila Jacobs

Publish Date March 14, 2022

Researchers analyzed the dynamic chest radiography and spirometry in patients with cystic fibrosis before and after starting triple combination CFTR modulator therapy.

Chronic Respiratory Disease, Comorbid Psychiatric Disorders, and Mortality

By

Virginia A. Schad, PharmD, RPh

Publish Date March 4, 2022

How do substance abuse and depression affect the risk for premature mortality in patients with common chronic respiratory and other conditions?

Combined ICS/LABA Therapy for Prematurity-Linked Lung Disease in Children

By

Sheila Jacobs

Publish Date February 2, 2022

Is combined inhaled corticosteroids/LABA therapy more effective than ICS alone in treating children born with chronic lung disease of prematurity?

Oral vs IV Antibiotics for Pseudomonas aeruginosa Infection in Patients With Cystic Fibrosis

By

Estie Mermelstein, MSN, FNP-BC

Publish Date January 18, 2022

Researchers conducted a study to compare the effects of intravenous vs oral antibiotics therapy in patients with a pulmonary infection caused by Pseudomonas aeruginosa secondary to cystic fibrosis.